Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
暂无分享,去创建一个
L. Schwartz | R. Motzer | J. Bacik | T. Mariani | M. Mazumdar | D. Cella | D. Fairclough | G. Wilding | B. Murphy | D. Nanus | P. Loehrer